Luke T.

Luke T. is currently a Principal Formulation Scientist at Immunocore Limited. They previously held positions as a Field Application Scientist at Wyatt Technology for four years, as Scientist 3 at Vectura Plc for 5.5 years, and worked at NHS Blood and Transplant for 1.5 years. Luke completed a PhD at the University of Manchester in 2018, focusing on the effects of denaturants on the aggregation propensity of monoclonal antibodies, which included work at AstraZeneca and the University of Delaware. They also obtained a Bachelor of Science in Biomedical Science with honors from the University of the West of England in 2007.